The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film
Nancy White, Robert Ali, Briony Larance, Deborah Zador, Richard P Mattick, Louisa Degenhardt
Drug and Alcohol Review | WILEY | Published : 2016
Awarded by National Health and Medical Research Council
The views expressed in this publication are not necessarily those of the Department for Correctional Services, New South Wales Justice Health and Forensic Mental Health Network or the South Australian Prison Health Service. L. D., B. L. and R. P. M. are supported by the National Health and Medical Research Council Research Fellowships (Nos. 1041472, 1073858 and 1045318). The National Drug and Alcohol Research Centre, UNSW, is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund.